Vanderbilt University v. ICOS Corporation
1:05-cv-00506
Overview
Parties
Defendant
ICOS Corporation NPE (Individual / Inventor)
Represented By
9 Attorneys ListedMorris James LLP
500 Delaware Avenue, Suite 1500, P.O. Box 2306
Morris James LLP
500 Delaware Avenue, Suite 1500, P.O. Box 2306
Marshall Gerstein & Borun LLP
233 South Wacker Drive, 6300 Sears Tower
Plaintiff
Vanderbilt University NPE (University / Research)
Represented By
6 Attorneys ListedBifferato Gentilotti Biden & Balick
Bifferato Gentilotti Biden & Balick, 1308 Delaware Avenue
Balick & Balick, LLC
Balick & Balick, LLC, 711 King Street
Bifferato Gentilotti LLC
Bifferato Gentilotti LLC, 100 Biddle Avenue, Suite 100
Whiteford, Taylor & Preston, L.L.C.
Whiteford, Taylor & Preston, L.L.C., 1220 N. Market Street, Suite 608
Third Party Defendant
Esquire Mark Rachlin NPE (Individual / Inventor)
Represented By
1 Attorneys ListedConnolly, Bove, Lodge & Hutz
Connolly, Bove, Lodge & Hutz, The Nemours Building
Glaxosmithkline NPE (University / Research)
Represented By
2 Attorneys ListedConnolly, Bove, Lodge & Hutz
Connolly, Bove, Lodge & Hutz, The Nemours Building
Connolly, Bove, Lodge & Hutz
Connolly, Bove, Lodge & Hutz, The Nemours Building
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 7 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 5,859,006 Asserted | Asserted Patent | View Official Patent → |
| 🇺🇸 United States | US 6,025,494 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,127,542 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,369,059 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,784,179 B2 | US Continuation / Sibling | View Official Patent → |
| 🇬🇧 United Kingdom | GB 9401090 | United Kingdom Counterpart | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 1995019978 A1 | PCT World Application | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5859006
Tetracyclic derivatives; process of preparation and use
|
Filed: 1995-01-19
Issued: 1999-01-12
|
Expired (Term Ended)
+1037d PTA
Expires: 2017-11-21
|
|
|
US6140329
Use of cGMP-phosphodiesterase inhibitors in methods and compositions to treat impotence
|
Filed: 1996-07-11
Issued: 2000-10-31
|
Expired (Term Ended)
Expires: 2016-07-11
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
High PTA (+1037 days) / Cellect Scrutiny — Over 1037 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
53
Dispositive
0
Granted
0
Denied
2
Pending / Review
18
Motions by Category
Key Dispositive Motions & Rulings